Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2019 029 658.4 |
96 | EP file number | EAKZ | 19 89 6754.9 |
86 | WO file number | WAKZ | PCT/CN2019/122455 |
97 | EP publication number | EPN | 3896057 |
87 | WO publication number | WPN | 2020119507 |
54 | Designation/title | TI | VERFAHREN ZUR KONTINUIERLICHEN HERSTELLUNG VON CITALOPRAM DIOL |
51 | IPC main class | ICM (ICMV) | C07C 253/30 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07C 255/59 (2006.01) |
22 | DE application date | DAT | Dec 2, 2019 |
96 | EP application date | EAT | Dec 2, 2019 |
86 | WO application date | WAT | Dec 2, 2019 |
43 | Date of first publication | OT | Jun 18, 2020 |
| Date of publication of grant | PET | May 31, 2023 |
71/73 | Applicant/owner | INH | Shanghai Aobo bio-pharmaceutical Co., Ltd., Shanghai, CN; Zhejiang Huahai Pharmaceutical Co., Ltd., Taizhou, Zhejiang, CN |
72 | Inventor | IN | LIU, Chen, Shanghai 201203, CN; LI, Xing, Shanghai 201203, CN; YE, Huaxiang, Shanghai 201203, CN; ZHANG, Jicheng, Shanghai 201203, CN; HUANG, Luning, Shanghai 201203, CN; TAO, Anping, Shanghai 201203, CN; AN, Jianguo, Shanghai 201203, CN; GU, Hong, Shanghai 201203, CN |
74 | Representative | VTR | Dantz IP & Law, 10719 Berlin, DE |
| Address for service | | Dantz IP & Law, 10719 Berlin, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| CN 201811518150 Dec 12, 2018
|
| Due date | FT FG | Dec 31, 2025 Annual fee for the 7th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003896057A1 Searchable text:
EP000003896057A1 Original document:
EP000003896057B1 Searchable text:
EP000003896057B1 Original document:
WO002020119507 Searchable text:
WO002020119507 |
43 | Date of first publication | EVT | Jun 18, 2020 |
| Date of the first transfer into DPMAregister | EREGT | Oct 20, 2021 |
| Date of the (most recent) update in DPMAregister | REGT | Dec 19, 2024 (Show all update days)(Hide all update days)- Dec 19, 2024
- Sep 12, 2024
- St.36: changed (technical change)
- May 30, 2024; May 23, 2024; Apr 18, 2024; Dec 15, 2023; Sep 28, 2023; Aug 18, 2023; Jun 15, 2023; May 6, 2023; May 4, 2023; Dec 1, 2022
- Historical data not available for this/these date(s)
- Oct 20, 2021
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Aug 17, 2023 |
| Issue number | HN | 39 |
| Year | PJ | 2023 |
| Publication date | VT | Sep 28, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Shanghai Aobo bio-pharmaceutical Co., Ltd., Shanghai, CN; Zhejiang Huahai Pharmaceutical Co., Ltd., Taizhou, Zhejiang, CN |
71/73 | Previous applicant/owner | INHF | Shanghai Aobo Pharmtech, Inc., Ltd., Shanghai, CN, Zhejiang Huahai Pharmaceutical Co., Ltd., Zhejiang, CN |
| Date of update of the procedure | REGT | Sep 28, 2023 |